A cost-minimization analysis of telemedicine vs standard induction for buprenorphine: Evidence from a randomized clinical trial in India.
Background: In-person buprenorphine induction poses substantial cost and access barriers in India's opioid agonist treatment programs, while telemedicine-assisted induction may offer a scalable, lower-cost alternative. Aim: To compare the societal costs of telemedicine-assisted buprenorphine inducti...
| Publicado en: | Indian Journal of Psychiatry Vol. 68; no. 7; pp. 609 - 616 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wolters Kluwer India Pvt Ltd
Jul2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |